
Rubius Therapeutics (NASDAQ:RUBY) is set to give its latest quarterly earnings report on Friday, 2022-02-25. Here's what investors need to know before the announcement.
Analysts estimate that Rubius Therapeutics will report an earnings per share (EPS) of $-0.59.